• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择用于用镓-68标记DARPin Ec1以进行EpCAM表达的PET成像的最佳螯合剂。

Selection of the optimal chelator for labeling of DARPin Ec1 with gallium-68 for PET imaging of EpCAM expression.

作者信息

Vorobyeva Anzhelika, Din Moeen-Ud, Schulga Alexey, Konovalova Elena, Abouzayed Ayman, Bragina Olga, Li Ruonan, Gräslund Torbjörn, Deyev Sergey M, Oroujeni Maryam

机构信息

Department of Immunology, Genetics and Pathology, Uppsala University, 751 85, Uppsala, Sweden.

Molecular Immunology Laboratory, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997, Moscow, Russia.

出版信息

EJNMMI Radiopharm Chem. 2025 May 30;10(1):26. doi: 10.1186/s41181-025-00347-6.

DOI:10.1186/s41181-025-00347-6
PMID:40445498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12125460/
Abstract

BACKGROUND

Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein, which is overexpressed in several types of malignancies. Designed ankyrin repeat protein (DARPin) Ec1 is a 19 kDa engineered scaffold protein that binds with high affinity to EpCAM. Radiolabelled Ec1 might be used as a companion diagnostic for the selection of patients for personalized therapy. This study aimed to investigate the influence of different radiometal-chelator complexes on the biodistribution and imaging contrast of Ga-labelled Ec1. To investigate this, two macrocyclic chelators, 1,4,7-triazacyclononane-N,N,N-triacetic acid (NOTA) and 1-(1,3-carboxypropyl)-1,4,7-triazacyclononane-4,7-diacetic acid (NODAGA) were conjugated to the C-terminus of the Ec1. The previously developed DARPin Ec1 conjugated to 1,4,7,10-tetraazacylododecane-1,4,7,10-tetraacetic acid (DOTA) was used as a comparator.

RESULTS

All Ec1 variants were successfully labelled with Ga. The use of NOTA and NODAGA provided twice higher radiochemical yield and improved label stability compared to DOTA. All labelled Ec1 variants bound to the EpCAM-expressing cells with nanomolar affinity and preserved targeting specificity in vitro and in vivo. Biodistribution studies in mice bearing EpCAM-expressing SKOV-3 xenografts showed that [Ga]Ga-Ec1-NOTA had lower uptake in most normal organs while maintaining tumor uptake. Among all variants, [Ga]Ga-Ec1-NOTA showed the lowest liver uptake, with no significant differences in tumor uptake. Additionally, [Ga]Ga-Ec1-NOTA provided the highest tumor-to-blood ratio compared to [Ga]Ga-Ec1-DOTA and [Ga]Ga-Ec1-NODAGA.

CONCLUSION

[Ga]Ga-Ec1-NOTA is the preferred radioconjugate for PET imaging of EpCAM expression.

摘要

背景

上皮细胞粘附分子(EpCAM)是一种跨膜糖蛋白,在多种恶性肿瘤中过度表达。设计锚蛋白重复蛋白(DARPin)Ec1是一种19 kDa的工程化支架蛋白,能与EpCAM高亲和力结合。放射性标记的Ec1可作为选择患者进行个性化治疗的伴随诊断剂。本研究旨在探讨不同放射性金属螯合剂复合物对镓标记的Ec1生物分布和成像对比度的影响。为研究此问题,将两种大环螯合剂,1,4,7-三氮杂环壬烷-N,N,N-三乙酸(NOTA)和1-(1,3-羧丙基)-1,4,7-三氮杂环壬烷-4,7-二乙酸(NODAGA)与Ec1的C末端偶联。将先前开发的与1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)偶联的DARPin Ec1用作对照。

结果

所有Ec1变体均成功用镓标记。与DOTA相比,使用NOTA和NODAGA可提供两倍更高的放射化学产率并提高标记稳定性。所有标记的Ec1变体均以纳摩尔亲和力与表达EpCAM的细胞结合,并在体外和体内保持靶向特异性。对携带表达EpCAM的SKOV-3异种移植瘤的小鼠进行的生物分布研究表明,[镓]镓-Ec1-NOTA在大多数正常器官中的摄取较低,同时保持肿瘤摄取。在所有变体中, [镓]镓-Ec1-NOTA的肝脏摄取最低,肿瘤摄取无显著差异。此外,与[镓]镓-Ec1-DOTA和[镓]镓-Ec1-NODAGA相比,[镓]镓-Ec1-NOTA提供了最高的肿瘤与血液比值。

结论

[镓]镓-Ec1-NOTA是用于EpCAM表达PET成像的首选放射性偶联物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5108/12125460/426b6d5243ee/41181_2025_347_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5108/12125460/a6955720c725/41181_2025_347_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5108/12125460/6e716d1e640f/41181_2025_347_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5108/12125460/db4308454333/41181_2025_347_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5108/12125460/f1bbe083887e/41181_2025_347_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5108/12125460/d0143d5207f2/41181_2025_347_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5108/12125460/611011787feb/41181_2025_347_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5108/12125460/426b6d5243ee/41181_2025_347_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5108/12125460/a6955720c725/41181_2025_347_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5108/12125460/6e716d1e640f/41181_2025_347_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5108/12125460/db4308454333/41181_2025_347_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5108/12125460/f1bbe083887e/41181_2025_347_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5108/12125460/d0143d5207f2/41181_2025_347_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5108/12125460/611011787feb/41181_2025_347_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5108/12125460/426b6d5243ee/41181_2025_347_Fig7_HTML.jpg

相似文献

1
Selection of the optimal chelator for labeling of DARPin Ec1 with gallium-68 for PET imaging of EpCAM expression.选择用于用镓-68标记DARPin Ec1以进行EpCAM表达的PET成像的最佳螯合剂。
EJNMMI Radiopharm Chem. 2025 May 30;10(1):26. doi: 10.1186/s41181-025-00347-6.
2
Influence of macrocyclic chelators on the targeting properties of (68)Ga-labeled synthetic affibody molecules: comparison with (111)In-labeled counterparts.大环螯合剂对(68)Ga 标记合成亲和体分子靶向特性的影响:与(111)In 标记物的比较。
PLoS One. 2013 Aug 1;8(8):e70028. doi: 10.1371/journal.pone.0070028. Print 2013.
3
Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1.放射性金属和放射性碘标记的位置及组成对使用DARPin Ec1的前列腺癌模型中Epcam表达成像的影响
Cancers (Basel). 2021 Jul 17;13(14):3589. doi: 10.3390/cancers13143589.
4
Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1.使用放射性标记的 DARPin Ec1 成像卵巢癌中 EpCAM 表达的可行性。
Int J Mol Sci. 2020 May 7;21(9):3310. doi: 10.3390/ijms21093310.
5
Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1.采用支架蛋白 DARPin Ec1 对三阴性乳腺癌中 EpCAM 表达的放射性核素分子成像。
Molecules. 2020 Oct 14;25(20):4719. doi: 10.3390/molecules25204719.
6
Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1.放射性标记生化性质对 EpCAM 结合工程支架蛋白 DARPin Ec1 肿瘤靶向特性的影响。
Int J Biol Macromol. 2020 Feb 15;145:216-225. doi: 10.1016/j.ijbiomac.2019.12.147. Epub 2019 Dec 19.
7
Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture.使用白蛋白结合域融合的设计锚蛋白重复蛋白靶向表达上皮细胞粘附分子的恶性肿瘤:分子结构的影响。
Int J Mol Sci. 2025 May 29;26(11):5236. doi: 10.3390/ijms26115236.
8
Visualization of epithelial cell adhesion molecule-expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with Tc and I.使用用锝和碘标记的设计锚蛋白重复序列蛋白Ec1对表达上皮细胞粘附分子的肾细胞癌异种移植瘤进行可视化。
Oncol Lett. 2022 Nov 17;25(1):12. doi: 10.3892/ol.2022.13598. eCollection 2023 Jan.
9
The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26.大环螯合剂对68Ga标记的胃泌素释放肽受体拮抗剂PEG2-RM26靶向特性的影响
Nucl Med Biol. 2015 May;42(5):446-454. doi: 10.1016/j.nucmedbio.2014.12.009. Epub 2014 Dec 20.
10
Development of a novel molecular probe for visualizing mesothelin on the tumor via positron emission tomography.通过正电子发射断层扫描开发一种用于可视化肿瘤上间皮素的新型分子探针。
Eur J Nucl Med Mol Imaging. 2025 Jan 29. doi: 10.1007/s00259-025-07087-4.

本文引用的文献

1
A whole-body imaging technique for tumor-specific diagnostics and screening of B7H3-targeted therapies.一种用于肿瘤特异性诊断和B7H3靶向治疗筛查的全身成像技术。
J Clin Invest. 2025 Jan 23;135(6):e186388. doi: 10.1172/JCI186388.
2
ImmunoPET imaging of EpCAM in solid tumours with nanobody tracers: a preclinical study.使用纳米抗体示踪剂对实体瘤中EpCAM进行免疫正电子发射断层显像:一项临床前研究。
Eur J Nucl Med Mol Imaging. 2025 Jan;52(2):388-400. doi: 10.1007/s00259-024-06910-8. Epub 2024 Sep 9.
3
Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [Tc]Tc(CO)-(HE)-Ec1 for Visualization of EpCAM-Expressing Lung Cancer.
用于可视化表达上皮细胞黏附分子(EpCAM)的肺癌的设计锚蛋白重复蛋白[锝]Tc(CO)-(HE)-Ec1的I期临床评估
Cancers (Basel). 2024 Aug 10;16(16):2815. doi: 10.3390/cancers16162815.
4
Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy.HER2 表达型癌症的亲和体PET成像作为指导HER2靶向治疗的关键
Biomedicines. 2024 May 14;12(5):1088. doi: 10.3390/biomedicines12051088.
5
Human Epidermal Growth Factor Receptor 2 (HER2) PET Imaging of HER2-Low Breast Cancer with [Ga]Ga-ABY-025: Results from a Pilot Study.人表皮生长因子受体 2(HER2)低表达乳腺癌的[Ga]Ga-ABY-025 PET 显像:一项初步研究结果。
J Nucl Med. 2024 May 1;65(5):700-707. doi: 10.2967/jnumed.123.266847.
6
Non-specific irreversible Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using Zr-immuno-PET.肿瘤中锆标记单克隆抗体的非特异性不可逆摄取:来自经活检证实为靶阴性肿瘤的锆免疫正电子发射断层扫描证据。
EJNMMI Res. 2024 Feb 15;14(1):18. doi: 10.1186/s13550-024-01079-5.
7
Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).分子成像预测晚期HER2阳性乳腺癌患者对T-DM1治疗无反应(ZEPHIR试验最终结果)
NPJ Breast Cancer. 2024 Jan 6;10(1):4. doi: 10.1038/s41523-023-00610-6.
8
HER2-Low Breast Cancer Can Be Visualized by HER2 PET.HER2低表达乳腺癌可通过HER2正电子发射断层显像(PET)进行可视化成像。
J Nucl Med. 2023 Nov;64(11):1841. doi: 10.2967/jnumed.123.266101. Epub 2023 Sep 14.
9
Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer.临床前评估 EpCAM 结合设计的锚蛋白重复蛋白 (DARPins) 作为双模态近红外荧光和光声成像癌症的靶向部分。
Eur J Nucl Med Mol Imaging. 2024 Jul;51(8):2179-2192. doi: 10.1007/s00259-023-06407-w. Epub 2023 Aug 29.
10
Human Epidermal Growth Factor Receptor 2-Targeting [Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer.人表皮生长因子受体 2 靶向 [Ga]Ga-ABY-025 PET/CT 预测转移性乳腺癌的早期代谢反应。
J Nucl Med. 2023 Sep;64(9):1364-1370. doi: 10.2967/jnumed.122.265364. Epub 2023 Jul 13.